Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis
Authors:
Open Access
- 12 January 2021
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 7 (1) , 1-13
Abstract
Epigenetic mechanisms such as histone modification play key roles in the pathogenesis of multiple myeloma (MM). We previously showed that EZH2, a histone H3 lysine 27 (H3K27) methyltransferase, and G9, a H3K9 methyltransferase, are potential therapeutic targets in MM. Moreover, recent studies suggest EZH2 and G9a cooperate to regulate gene expression. We therefore evaluated the antitumor effect of dual EZH2 and G9a inhibition in MM. A combination of an EZH2 inhibitor and a G9a inhibitor strongly suppressed MM cell proliferation in vitro by inducing cell cycle arrest and apoptosis. Dual EZH2/G9a inhibition also suppressed xenograft formation by MM cells in vivo. In datasets from the Gene Expression Omnibus, higher EZH2 and EHMT2 (encoding G9a) expression was significantly associated with poorer prognoses in MM patients. Microarray analysis revealed that EZH2/G9a inhibition significantly upregulated interferon (IFN)-stimulated genes and suppressed IRF4-MYC axis genes in MM cells. Notably, dual EZH2/G9a inhibition reduced H3K27/H3K9 methylation levels in MM cells and increased expression of endogenous retrovirus (ERV) genes, which suggests that activation of ERV genes may induce the IFN response. These results suggest that dual targeting of EZH2 and G9a may be an effective therapeutic strategy for MM.Keywords
This publication has 48 references indexed in Scilit:
- Enhancer of Zeste Homolog 2 Is a Negative Regulator of Mitochondria-Mediated Innate Immune ResponsesThe Journal of Immunology, 2013
- G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitmentGenes & Development, 2012
- Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon responseJournal of Experimental Medicine, 2012
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cellsNature Chemical Biology, 2011
- Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem CellsCell, 2009
- IRF4 addiction in multiple myelomaNature, 2008
- Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2′-deoxycytidine treatment is associated with activation of the interferon signalling pathwayOncogene, 2005
- Comprehensive Analysis of Human Endogenous Retrovirus Transcriptional Activity in Human Tissues with a Retrovirus-Specific MicroarrayJournal of Virology, 2005
- Interferon-α-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and BaxOncogene, 2003
- Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-αExperimental Hematology, 2000